Stability of the COVID-19 virus under wet, dry and acidic conditions

preprint OA: gold CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

COVID-19 has become a pandemic and is spreading fast worldwide. The COVID-19 virus is transmitted mainly through respiratory droplets and close contact. However, the fecal-oral transmission of the virus has not been ruled out and it is important to ascertain how acidic condition in the stomach affects the infectivity of the virus. Besides, it is unclear how stable the COVID-19 virus is under dry and wet conditions. In the present study, we have shown that the COVID-19 virus is extremely infectious as manifested by the infection of Vero-E6 cells by one PFU (Plaque Forming Unit) of the virus. We then investigated the stability of the COVID-19 virus in wet, dry and acidic (pH2.2) environments at room temperature. Results showed that the COVID-19 virus could survive for three days in wet and dry environments, but the dry condition is less favorable for the survival of the virus. Our study also demonstrated that the COVID-19 virus at a relative high titer (1.2 x 103 PFU) exhibits a certain degree of tolerance to acidic environment at least for 60 minutes. When the virus titer was ≤1.0 x 103 PFU, acid treatment (pH2.2) for 30 or 60 minute resulted in virus inactivation. It suggests that the virus at a high concentration may survive in the acidic environment of the stomach. The finding of the present study will contribute to the control of the spread of the COVID-19 virus.
Full text 14,053 characters · extracted from oa-pdf · click to expand
Stability of the COVID-19 virus under wet, dry and acidic conditions Zhi-ping Sun1*, Xia Cai1*, Chen-jian Gu2*, Rong Zhang2*, Wen-dong Han1, Yun Qian1, Yu-yan Wang2, Wei Xu 2, Yang Wu2, Xunjia Cheng 2, Zheng-hong Yuan2**, You-hua Xie2**, Di Qu1, 2** 1 BSL-3 laboratory of Fudan University, School of Basic Medical Sciences, Shanghai Medical College, Fudan University 2 Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University * Co-first author **Corresponding author Di Qu: [email protected] You-hua Xie: [email protected] Zheng-hong Yuan: [email protected] . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. To the Editor, An outbreak of pneumonia caused by a novel coronavirus was reported in December 2019 in Wuhan, Hubei Province of China [1-3]. The COVID-19 virus (SARS- COV-2) has spread to every continent and WHO declared COVID-19 as a pandemic [4]. In this study, the presence of CPE was used as the main index for the detection of the infectivity of the COVID-19 virus. When CPE was not observed, immunofluorescence of intracellular viral N protein and RT-PCR of viral RNA in the cell culture supernatant were used for the detection of viral infection. The strain nCoV -SH01 (GenBank accession no. MT121215) used in this study was isolated and plaque -purified from the nasal-pharyngeal swab of a clinically confirmed COVID-19 patient in Shanghai [5]. Using the strain nCoV-SH01 and these criteria, we first investigated the infectivity of the COVID-19 virus. We found that as the virus titer decreases (2000, 1000, 500, 250, 100, 50, 10, 5, and 1 PFU), the time for CPE to appear is delayed. One PFU is able to cause infection of Vero- E6 cells, resulting in obvious CPE at 72 hours, whereas higher titer of the virus induced CPE at 24 hours post inoculation (Table 1). It indicates that the COVID-19 virus is highly infectious, and underscores the challenge to control the spread of the COVID-19 virus. We then studied the stability of the COVID-19 virus in the wet (in 100 uL culture medium) and dry (10 uL supernatant on filter paper) environments at room temperature (22℃) for 1, 2, 3, 4, 5, 6, 7 days respectively . Our results show that the COVID-19 virus can survive for 3 days in the wet or dry environment investigated in this study . Although the virus maintained its infectivity within 3 days in the dry condition, CPE appeared later than that kept in the wet environment, indicating that the dry environment may be less favorable for the survival o f the COVID-19 virus (Table 2 & Table 3 ). However, when the virus had been kept in the wet or dry condition for more than 4 days, no CPE was observed (Table 2 & Table 3) , which was confirmed by immune florescence staining (data not shown) with the antibody against viral N protein as well as qRT-PCR. We further investigated the stability of the COVID-19 virus at pH2.2 condition. It shows that the COVID-19 virus has a certain degree of tolerance to acidic environment. In the present study, w hen 1.2 x 10 3 PFU of the COVID -19 virus were treated with acidic saline of pH2.2 for 30 or 60 minutes, it still resulted in CPE in the cells, whereas 1.0 x 103 PFU of the COVID-19 virus treated with pH2.2 saline for 30 or 60 minute, no CPE were observed (Table 4). It suggests under the acidic condition the COVID-19 . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint virus at a relatively high titer can survive under acidic condition for at least 1 hour. In conclusion, our findings show that the COVID-19 virus is highly infectious that one PFU can results in cell infection in our in vitro system, and can survive for 3 days in the wet or dry environment . In addition, we for the first time demonstrated that the COVID-19 virus at relative high concentrations can survive under acidic condition that minic the gastric environment. The study would also provide guidance on taking appropriate measures to control the spread of the COVID -19 virus and improve laboratory safety. The study was supported by the National Science and Technology Major Project (NSTMP) for the Prevention and Treatment of Infectious Diseases (2018ZX10734401, 2018ZX10301208), NSTMP for the Development of Novel Drugs (2019ZX09721001), and Project of Novel Coronavirus Research of Fudan University. Reference 1. Wang, C., et al., A novel coronavirus outbreak of global health concern. Lancet, 2020. 395(10223): p. 470-473. 2. Qun Li, X.G., Peng Wu, Xiaoye Wang, Lei Zhou, Yeqing Tong, Ruiqi Ren, Kathy S.M. Leung, Eric H.Y . Lau, Jessica Y . Wong, Xuesen Xing, Nijuan Xiang, Yang Wu, Chao Li, Qi Chen, Dan Li, Tian Liu, Jing Zhao, Man Liu, Wenxiao Tu, Chuding Chen, Lianmei Jin, Rui Yang, Qi Wang, Suhua Zhou, Rui Wang, Hui Liu, Yinbo Luo, Yuan Liu, Ge Shao, Huan Li, Zhongfa Tao, Yang Yang, Zhiqiang Deng, Boxi Liu, Zhitao Ma, Yanping Zhang, Guoqing Shi, Tommy T.Y . Lam, Joseph T. Wu, George F. Gao, D.Phil., Benjamin J. Cowling, Bo Yang, Gabriel M. Leung, Zijian Feng, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. The New England Journal of Medicine, 2020(382): p. 1199. 3. The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Q.L., Notes from the Field: An Outbreak of NCIP (2019-nCoV) Infection in China — Wuhan, Hubei Province, 2019- 2020. China CDC Weekly, 2020. 2(5): p. 79-80. 4. Organization, W.H. There is a current outbreak of Coronavirus (COVID-19) disease. 2020; Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1 . 5. Zhang Rong, Y .Z., Wang Yuyan, Teng Zheng, Xu Wei, Song Wuhui, Cai Xia, Sun Zhiping, Gu Chenjian, Zhou Yanqiu, Chen Hongyou, Ye Rong, Han Wendong, Zhu Yunkai, Feng Fanghao, Li Chongshan, Zhang Xi, Qu Di, Fu Chen, Xie Youhua, Yuan Zhenghong, Isolation of a 2019 novel coronavirus strain from a coronavirus disease 19 patient in Shanghai. Journa of Microbes and Infections, 2020. 15(1): p. 15-20. . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint Table 1. The cytopathic effect of Vero-E6 cell infected by different PFU of the COVID-19 virus Time (d.p.i.)# Cell control Viral inoculation ( x 102 PFU)* 20 10 5 2.5 1 0.5 0.1 0.05 0.01** 1 - ++++ ++++ ++ + - - - - - - - 2 - / ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ - - 3 - / / / / / / ++++ ++++ ++++ ++++ ++++ #, d.p.i. days post-inoculation. CPE of V ero E6 cells was checked under microscope. Degree of CPE, “++++”, >75% of cells; “+++”, 50%~75%; “++”, 25%~50%; “+”, 0~25% * The experiments were carried out in triplicate wells for each dilution. The cell control was without the virus. The cytopathic effects were observed under a microscope daily for 3 days. ** In the triplicate wells inoculated with 0.01x102 PFU, CPE appeared at different time points in individual wells and was separately presented. . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint Table 2. Stability of the COVID-19 virus under wet condition Time (d.p.i.)# Infectivity of 1.2×103 PFU virus treated at room temperature under wet condition** Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 1 ++ ++ ++ ++ ++ ++ - - - ± ± ± - - - - - - - - - - - - 2 CPE ++++ ++++ ++++ ++++ ++++ ++++ + + +++ + ++ ++ - - - - - - - - - - - - ORF1ab* N* 15.61±0.28 15.99±0.10 15.64±0.09 15.66±0.04 15.74±1.13 16.27±0.06 33.36±1.05 32.92±1.33 UD UD UD UD UD UD UD UD 3 / / / / / / +++ + +++ + +++ + ++ ++ +++ - - - - - - - - - - - - 4 / / / / / / / / / +++ ++ +++ ± ± ± ± ± ± - - - - - - 5 CPE / / / / / / / / / +++ +++ +++ ± ± ± ± ± ± - - - - - - ORF1ab* N* ND ND ND ND UD UD UD UD UD UD UD UD 6 / / / / / / / / / / / / - - - - - - - - - - - - 7 / / / / / / / / / / / / - - - - - - - - - - - - 8 / / / / / / / / / / / / - - - - - - - - - - - - #, d.p.i. days post-inoculation. CPE of V ero E6 cells was checked under microscope. Degree of CPE, “++++”, >75% of cells; “+++”, 50%~75%; “++”, 25%~50%; “+”, 0~25%; “±”, not clear-cut; “-”, no CPE. * The Viral RNA in the supernatant after 2-day and 5-day incubation was extracted. Quantitative RT-PCR was performed using the primers and probes for viral ORF1ab and N (listed in Table 1). Ct values were presented as Mean ± SD. Cutoff value: Ct value > 38. UD: under detectable level. ND: Not determined. ** The experiments were carried out in triplicate wells for each dilution. The cytopathic effects were observed under a microscope daily for 8 days. . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint Table 3. Stability of the COVID-19 virus under dry condition. Time (d.p.i.)# Infectivity of 1.2×103 PFU virus treated at room temperature under dry condition** Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 1 - - - ± ± ± - - - - - - - - - - - - - - - - - - 2 CPE ++++ ++++ ++++ + + + + - + ± ± ± - - - - - - - - - - - - ORF1ab* N* 15.25±0.22 15.06±0.59 29.05±0.45 28.60±0.15 35.09±0.18 35.12±0.42 35.74±0.09 35.98±0.19 UD UD UD UD UD UD UD UD 3 / / / + + + + + + ± ± ± - - - - - - - - - - - - 4 / / / ++++ ++ + + + + ± ± ± ± ± - - - - - - - - - - 5 CPE / / / ++++ ++ ++ ++ ++ + + + + ± ± ± ± ± ± - - - - - - ORF1ab* N* ND ND ND ND UD UD UD UD UD UD UD UD 6 / / / / +++ +++ +++ +++ + ++ ++ ++ - - - - - - - - - - - - 7 / / / / +++ +++ +++ +++ + ++ ++ ++ - - - - - - - - - - - - 8 / / / / / / / / + ++ ++ ++ - - - - - - - - - - - - #, d.p.i. days post-inoculation. CPE of V ero E6 cells was checked under microscope. Degree of CPE, “++++”, >75% of cells; “+++”, 50%~75%; “++”, 25%~50%; “+”, 0~25%; “±”, not clear-cut; “-”, no CPE. * The Viral RNA in the supernatant after 2-day and 5-day incubation was extracted. Quantitative RT-PCR was performed using the primers and probes for viral ORF1ab and N (listed in Table 1). Ct values were presented as Mean ± SD. Cutoff value: Ct value > 38. UD: under detectable level. ND: Not determined. ** The experiments were carried out in triplicate wells for each dilution. The cytopathic effects were observed under a microscope daily for 8 days. . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint Table 4. Stability of the COVID-19 virus under acidic condition #, d.p.i. days post-inoculation. CPE of V ero E6 cells was checked under microscope. Degree of CPE, “++++”, >75% of cells; “+++”, 50%~75%; “++”, 25%~50%; “+”, 0~25%; “±”, not clear-cut; “-”, no CPE. * The experiments were carried out in triplicate wells for each dilution. The virus control was treated with physiological saline (final pH = 7.12) for 60 min. Physiological saline (pH = 7.0) was used as a blank control. The cytopathic effects were observed under a microscope daily for 5 days. ** The 0.05 x102 PFU group (30 seconds) showed CPE (++++) in 1 well at 72 hrs, and all become ++++ at 96 hrs. Time (d.p.i)# Treatment under acidic condition* Virus control 60 min (pH 7.12) Cell control (pH 7.0) 30 s (pH 2.2) 30 min (pH 2.2) 60 min (pH 2.2) Inoculated virus (x102 PFU) Inoculated virus (x102 PFU) Inoculated virus (x102 PFU) (x102 PFU) 12 10 5 1 0.2 0.05 0.01 12 10 5 1 0.2 0.05 0.01 12 10 5 1 0.2 0.05 0.01 12 0.01 No virus 1 +++ ++ - - - - - - - - - - - - - - - - - - - ++++ - - 2 ++++ ++++ ++++ - - - - ++++ - - - - - - ++++ - - - - - - ++++ - - 3 / / / ++++ ++++ ++++ ** - / - - - - - - / - - - - - - / ++++ - 4 / / / / / ++++ - / - - - - - - / - - - - - - / / - 5 / / / / / / - / - - - - - - / - - - - - - / / - . CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprintthis version posted April 14, 2020. ; https://doi.org/10.1101/2020.04.09.20058875doi: medRxiv preprint

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0